Progyny, Inc. (PGNY) Cash and securities
- Total cash · latest quarter (USD): Value $236.93M; Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | $236.93M | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. $152.63M + $84.29M ≈ $236.93M |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 152.63M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 84.29M USD | Marketable Securities, Current · Debt Securities, Available-for-sale, Current |
| Cash and current securities | 236.93M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | $236.93M | (m) | $152.63M | $84.29M | (m) |
| 2026-03-31 | $225.11M | (m) | $131.61M | $93.50M | (m) |
| 2025-12-31 | $310.10M | (m) | $112.24M | $197.86M | (m) |
| 2025-09-30 | $345.21M | (m) | $133.98M | $211.22M | (m) |
| 2025-06-30 | $305.09M | (m) | $132.51M | $172.59M | (m) |
| 2025-03-31 | $256.12M | (m) | $109.24M | $146.88M | (m) |
| 2024-12-31 | $227.95M | (m) | $162.31M | $65.64M | (m) |
| 2024-09-30 | $235.72M | (m) | $91.48M | $144.24M | (m) |
| 2024-06-30 | $262.19M | (m) | $94.96M | $167.23M | (m) |
| 2024-03-31 | $371.83M | (m) | $114.96M | $256.87M | (m) |
| 2023-12-31 | $371.09M | (m) | $97.30M | $273.79M | (m) |
| 2023-09-30 | $335.55M | (m) | $158.07M | $177.48M | (m) |
| 2023-06-30 | $282.50M | (m) | $170.57M | $111.92M | (m) |
| 2023-03-31 | $207.89M | (m) | $155.32M | $52.57M | (m) |
| 2022-12-31 | $189.30M | (m) | $120.08M | $69.22M | (m) |
| 2022-09-30 | $140.99M | (m) | $72.52M | $68.47M | (m) |
| 2022-06-30 | $122.39M | (m) | $54.73M | $67.66M | (m) |
| 2022-03-31 | $105.68M | (m) | $38.82M | $66.86M | (m) |
| 2021-12-31 | $119.42M | (m) | $91.41M | $28.00M | (m) |
| 2021-09-30 | $114.31M | (m) | $92.22M | $22.09M | (m) |
| 2021-06-30 | $93.97M | (m) | $48.75M | $45.22M | (m) |
| 2021-03-31 | $106.92M | (m) | $29.82M | $77.09M | (m) |
| 2020-12-31 | $109.30M | (m) | $70.31M | $38.99M | (m) |
| 2020-09-30 | $104.96M | (m) | $53.97M | $50.99M | (m) |
| 2020-06-30 | $91.38M | (m) | $49.39M | $41.98M | (m) |
| 2020-03-31 | (m) | (m) | $91.63M | (m) | (m) |
| 2019-12-31 | (m) | (m) | $80.38M | (m) | (m) |
| 2019-09-30 | (m) | (m) | $7.66M | (m) | (m) |
| 2018-12-31 | (m) | (m) | $127.00K | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |